Aim The aim was to assess factors independently associated with low anterior resection syndrome (LARS) following resection for rectal cancer.
Method This was a cross-sectional study carried out in two acute-care teaching hospitals in Barcelona, Spain. Patients who had undergone sphincter-preserving low anterior resection with curative intent with total or partial mesorectal excision (with and without protective ileostomy) between January 2001 and December 2009 completed a self-administered questionnaire to assess bowel dysfunction after rectal cancer surgery. Predictors of LARS were assessed by univariate and multivariate analyses.
Results
The questionnaire was sent to 329 patients (response rate 57.7%). Six cases of incomplete questionnaires were excluded. The study population included 184 patients (66.8% men) with a mean age of 63 years. There were 44 (23.9%) patients with no LARS, 36 (19.6%) with minor LARS and 104 (56.2%) with major LARS. In the univariate analysis, total mesorectal excision (P = 0.0008), protective ileostomy (P = 0.002), preoperative and postoperative radiotherapy (P = 0.0000), postoperative chemotherapy (P = 0.0046) and age (P = 0.035) were significantly associated with major LARS, whereas in the multivariate analysis total mesorectal excision (OR 2.18, 95% CI: 1.02-4.65), preoperative radiotherapy (OR 4.33, 95% CI: 2.03-9.27) and postoperative radiotherapy (OR 9.52, 95% CI: 1.74-52.24) were independent risk factors for major LARS.
Introduction
Radical treatment of rectal cancer usually involves excision of the affected rectum by means of low anterior resection with sphincter preservation or an abdominoperineal resection. Total mesorectal excision is now established as the therapeutic gold standard for middle and lower third rectal cancers. Most upper rectal cancers are treated with sphincter-preserving resection and partial mesorectal excision [1] . In these cases, the minimum distal margin of resection remains a matter of debate, although a distal margin of resection of 1 cm below the edge of the cancer (measured on the pathological specimen) may be appropriate clearance for most patients [2, 3] . Also, radiation therapy has been established as a standard of care for locally advanced rectal cancer [4] . Major defaecatory problems frequently occur after rectal surgery and include stool incontinence, constipation, clustering of stools, frequency/urgency of stools, abdominal pain and/or increased gas [5] [6] [7] . It is well recognized that the height of the anastomosis and previous radiotherapy are predisposing factors. Such symptoms are collectively referred to as the low anterior resection syndrome (LARS). Between 25% and 80% of patients undergoing low anterior resection will suffer from LARS [5, 8] . The aetiology of LARS is multifactorial and includes sphincter injury during construction of the anastomosis, alterations in anorectal physiology, the development of a pudendal neuropathy and a lumbar plexopathy. Symptoms are exacerbated if there is associated anastomotic sepsis or following the use of adjuvant and neoadjuvant therapies [9] . There is limited evidence suggesting that the symptoms of LARS may be obviated by the formation of a neorectal reservoir or by side to side anastomosis [9, 10] . Despite the fact that LARS is a significant and not uncommon problem a recent survey of colorectal surgeons suggests that awareness of the syndrome, its risk factors and treatment options is low [11] .
The development of a five-item LARS score by a group of Danish authors [12] has facilitated the study of this syndrome. The aim of this study was to evaluate the relationship between various clinical variables and the development of LARS using the LARS score.
Method
This was a cross-sectional study using prospectively collected information from two acute-care teaching hospital databases in Barcelona (Spain). All patients who were diagnosed with rectal cancer and had undergone sphincter-preserving low anterior resection with curative intent at the participating hospitals between January 2001 and December 2009 were eligible. The objective of the study was to identify factors determining LARS after rectal cancer resection. Inclusion criteria included age 18 years or older, the absence of metastatic disease, and comprehension of Spanish. Patients with a permanent stoma, metastatic disease and those receiving oncological treatment were excluded from the study. The ethics committee of all participating centres approved the study. Written informed consent was obtained from all patients.
On entry into the study patients received an invitation letter in which they were asked to complete a validated simple self-administered questionnaire designed to assess bowel dysfunction after rectal cancer surgery [13] . All received a pre-paid addressed envelope. After a period of 2 weeks, patients who did not respond were contacted by phone to check the address and whether or not they had received the questionnaire. All non-responders received the questionnaire as a second reminder. The whole process was completed over a 2-month period.
The LARS questionnaire includes the following five questions: Do you ever have occasions when you cannot control your flatus (wind)? Do you ever have any accidental leakage of liquid stool? How often do you open your bowels? Do you ever have to open your bowels again within 1 h of the last bowel opening? Do you ever have such a strong urge to open your bowels that you have to rush to the toilet? The allocated points per question are indicated in the questionnaire, and the score from each of the five answers is added together to give a final score between 0 and 42. Interpretation is as follows: 0-20, no LARS; 21-29, minor LARS; 30-42, major LARS [12] .
The following data were recorded: age; gender; operative details [protective ileostomy, requirement of an ileostomy because of postoperative complications (socalled secondary ileostomy)]; time until stoma closure; total or partial mesorectal excision; postoperative complications including radiological or clinical evidence of anastomotic leak; tumour staging; and neoadjuvant and adjuvant radiochemotherapy.
Statistical analysis
Categorical variables are expressed as frequencies and percentages, and continuous variables as mean and standard deviation or median and interquartile range (25-75th percentile). The chi-squared (v 2 ) test or Fisher's exact test was used for the comparison of categorical variables, and Student's t-test or the Mann-Whitney U test for the comparison of quantitative variables. Univariate analysis was performed first to identify factors which had a significant association with LARS. Subsequently, multivariate analysis was performed to determine what the strongest predictors of the LARS criterion were. Statistical significance was set at P < 0.05. Results are expressed as odds ratio with 95% confidence interval. Data were analysed using R software version 2.9.0 (R Project for Statistical Computing, Vienna, Austria).
Results
The LARS questionnaire was sent to 329 patients. A total of 190 responded (response rate 57.7%) (n = 190). Incomplete questionnaires (n = 6) were excluded from the analysis. Therefore, the study population included 184 patients, 123 men and 61 women, with a mean age of 63 years. Major LARS was significantly more frequent in patients who underwent total mesorectal excision compared with partial mesorectal excision (64.2% vs 36%, P < 0.0001), in those with a protective ileostomy vs those without ileostomy (67% vs 44%, P < 0.0001) and in patients treated with preoperative radiotherapy vs those who did not receive preoperative radiotherapy (67.2% vs 35.5%, P < 0.0001; Table 1 ).
Differences were also found between patients treated with postoperative radiotherapy vs those who did not receive postoperative radiotherapy (80% vs. 54.9%, P < 0.0001), but only 10 patients were treated with postoperative radiation therapy.
In the univariate analysis, the following variables were significantly associated with major LARS: mesorectal excision (P = 0.0008), protective ileostomy (P = 0.002), preoperative and postoperative radiotherapy (P = 0.0000), postoperative chemotherapy (P = 0.0046) and age (P = 0.035; Table 2 ). In contrast, gender, anastomotic leak, need for secondary stoma due to sepsis, pT stage and time interval from creation to closure of the ileostomy were not associated with development of major LARS. In the multivariate analysis, variables independently associated with major LARS were total mesorectal excision (OR 2.18, 95% CI: 1.02-4.65), preoperative radiotherapy (OR 4.33, 95% CI: 2.03-9.27) and postoperative radiotherapy (OR 9.52, 95% CI: 1.74-52.24), whereas age was marginally significant (Table 3) .
Discussion
This study investigated factors that predispose to the development of major LARS using a validated LARS score in 184 patients. Our results suggest that mesorectal excision is an important factor in the development of LARS. Whilst some studies have suggested that the level of the anastomosis does not influence functional outcome after resection for rectal cancer [14] , there is evidence to suggest [15] [16] [17] [18] that impaired function after rectal resection is related to reduced neorectal compliance that occurs in association with lower anastomoses.
Thus, as much residual rectum as possible should be preserved without compromising adequate oncological clearance. In our study, total mesorectal excision was an independent risk factor for LARS as has been shown in other studies [15, 16] . Radiotherapy plays a central role in the primary treatment of locally advanced rectal cancer [4] . However, preoperative radiation therapy in the multimodal treatment approach of rectal cancer patients has been associated with a negative effect on anorectal function after total mesorectal excision [19] [20] [21] . Chen et al. [22] reported that even following short-course radiotherapy 46% of patients developed major LARS after a median interval from treatment of 14.6 years. In our experience, both preoperative and postoperative radiotherapy were significant factors associated with LARS, with an odds ratio of 4.33 and 9.52, respectively. These findings emphasize the need for a personalized approach and careful selection of patients for radiation therapy.
There are conflicting data on the effect of a diverting stoma on the incidence and severity of functional alterations following anterior resection. Using a healthrelated quality of life questionnaire, Herrle et al. [23] investigated the impact of a diverting stoma on the quality of life of patients undergoing rectal cancer resection and found that the presence of a stoma had a negative impact on social functioning and gastrointestinal symptoms. However, in other studies in which a questionnaire was used to evaluate anorectal function, no differences between patients with and without a temporary defunctioning stoma were found [24, 25] . The results of this study did suggest an association between a diverting stoma and LARS on univariate analysis but this was not confirmed on multivariate analysis. One possible explanation for this was that patients with a diverting ileostomy were those who more frequently underwent total mesorectal excision. Moreover, impairment of defaecatory function was not influenced by the interval between construction and stoma closure, so that early ileostomy reconstruction did not seem to improve functional outcome in these patients. Defaecatory dysfunction was not observed in a few patients with sepsis in whom creation of a secondary ileostomy was necessary. Lindgren et al. [25] reported the results of a secondary analysis of a randomized controlled study carried out in 181 patients (90 in the stoma group and 91 without stoma). In this study, a defunctioning stoma did not affect anorectal function after low anterior resection and being without a stoma for 12 months, which is consistent with our findings.
Some studies have shown an increased risk of LARS following an anastomotic leak [26] [27] [28] possibly due to increased fibrosis induced by inflammation, causing a reduced neorectal capacity and compliance. In these studies, however, there was no uniform definition of anastomotic leak. Further, no validated scores for the assessment of defaecatory function were used. In a study reported by Bittorf et al. [29] evaluation of continence function was based on the Cleveland Clinic Continence Score and functional outcome in patients after anastomotic leakage did not differ significantly from that in patients without complications. In the present study, anastomotic leak was not associated with LARS. Patient factors such as age and gender have also been shown to be important factors, although the results are not consistent. [30, 31] . In the present series, age was marginally significant and we believe that the patient's age is a factor that should be considered for the decisionmaking process regarding the technique of choice and the indication of a colorectal anastomosis, assessing the sum of the effects produced by the association of other variables that negatively affect the defaecatory function.
We recognize that our study has certain limitations which include a non-response rate of 42.3% and the retrospective data collection from the databases of two different colorectal units in which technical decisions regarding the type of procedure were not standardized. Further, small numbers preclude definitive interpretations regarding the significance or otherwise of anastomotic leak rate, secondary stoma formation and postoperative radiation therapy. The nature of anastomoses and chemotherapeutic agents were not evaluated because of their heterogeneity. However, our study provides further evidence on risk factors for LARS.
Long-course chemoradiotherapy has been advocated as an alternative strategy to surgery in selected patients, which would avoid radical surgery and therefore LARS altogether [32] . However, this is an area with insufficient robust evidence for which further review and comparison are needed [33] .
In summary, using a standard validated questionnaire to assess LARS, this study found a high incidence of major LARS of 56.5% after low anterior resection. Total mesorectal excision and radiation therapy both in the neoadjuvant and adjuvant setting were significant risk factors for LARS. In relation to the role of adjuvant radiotherapy, the present findings should be interpreted with caution as only 10 patients were treated with postoperative radiotherapy. Other factors, such as protective ostomy, adjuvant chemotherapy and age were related to major LARS at univariate testing but lost their significance in the multivariate analysis. Further studies using the validated LARS score questionnaire are necessary, so that comparison of the impact of functional disturbances in surviving rectal cancer patients following sphincter-sparing procedures in different clinical series may be performed.
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